Jacobs Levy Equity Management’s Epizyme, Inc EPZM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-587,164	Closed	-$1.47M	–	1126
2021 Q4	$1.47M	Buy	+587,164	New	+$2.31M	0.01%	676
2021 Q3	–	Sell	-156,890	Closed	-$1.3M	–	1162
2021 Q2	$1.3M	Buy	+156,890	New	+$1.32M	0.01%	691
2019 Q2	–	Sell	-35,050	Closed	-$434K	–	1059
2019 Q1	$434K	Sell	35,050 -73,325	-68%	-$820K	0.01%	797
2018 Q4	$668K	Buy	108,375 +18,000	+20%	+$137K	0.01%	685
2018 Q3	$958K	Buy	90,375 +18,825	+26%	+$215K	0.01%	654
2018 Q2	$970K	Buy	71,550 +25,300	+55%	+$394K	0.02%	670
2018 Q1	$821K	Buy	46,250 +1,260	+3%	+$21.3K	0.01%	678
2017 Q4	$565K	Buy	44,990 +31,600	+236%	+$459K	0.01%	726
2017 Q3	$255K	Buy	+13,390	New	+$204K	0.01%	818
2016 Q4	–	Sell	-22,400	Closed	-$220K	–	1088
2016 Q3	$220K	Sell	22,400 -15,800	-41%	-$144K	﹤0.01%	885
2016 Q2	$391K	Buy	+38,200	New	+$426K	0.01%	821